IFIGENEIA – Excellence Hubs for Innovation in Nuclear Medicine with LINAC (Linear Accelerator) Technology
The IFIGENEIA project addresses the challenges of modern nuclear medicine by introducing advanced LINAC (Linear Accelerator) technology as a sustainable and environmentally friendly alternative to traditional radioisotope production sources. The project will establish three Excellence Hubs in Greece, Slovenia, and Cyprus, serving as innovation centers for the development, validation, and commercialization of radioisotopes and related technologies. The main goal is to support research, diagnostics, therapy, and theranostics by utilizing LINAC technology, which enables high flexibility, safety, and accessibility. Each Hub brings together key stakeholders from research, industry, public sector, and civil society in a quadruple-helix model, while aligning with regional RIS3 strategies. In addition to the technological dimension, the project includes the development of investment strategies, the strengthening of entrepreneurial skills, and mentoring activities for Western Balkan countries, with the aim of fostering long-term European integration and knowledge transfer.